Apr 28, 2020
The Global Tuberculosis Drugs Market is expected to grow from USD 1,483.27 Million in 2018 to USD 2,182.39 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.67%
Mar 04, 2020
Insmed Announces Publication Discussing the Clinical Management of Common Respiratory Events Associated with ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in the Journal Open Forum Infectious Disease
Feb 28, 2020
JLK Inspection has announced signing of a partnership with the National TB Center (NTC) and the Clinton Health Access Initiatives (CHAI) in Lao PDR to conduct a tuberculosis screening project
Feb 12, 2020
TB Alliance Names Dr. Daniel Everitt Vice President and Chief Medical Officer
Feb 03, 2020
Jane Griffiths Joins TB Alliance Board of Directors
Jan 31, 2020
Immunitor unveils breakthrough immunotherapy to treat tuberculosis in as short as one month
Jan 07, 2020
Rapid Diagnostics Announces Completion of Asset Purchase and New Corporate Strategies
Nov 14, 2019
Global therapeutic BCG vaccines market is expected to grow with a CAGR of 4.5% over the forecast period from 2019-2025
Oct 23, 2019
Global Nontuberculous Mycobacterial Infections Pipeline Report 2019: Therapeutic Candidates in Discovery and Preclinical, Phase 1, Phase 2, and Phase 3 Stage
Oct 11, 2019
Shionogi enters into a new license agreement and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics, Inc.
Aug 14, 2019
FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis
Aug 14, 2019
FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs
Aug 14, 2019
FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis
Jul 23, 2019
Global Latent Tuberculosis Infection Testing Market 2019-2023: Rising Prevalence of HIV and Increasing Government Initiatives to Drive Market Growth
Jun 12, 2019
Mitchell Warren Elected President of TB Alliance Stakeholders Association, Joins Board of Directors
Jun 06, 2019
FDA Advisory Committee Votes Favorably on the Question of the Effectiveness and Safety of Pretomanid in Combination with Bedaquiline and Linezolid for Treatment of Highly Drug-Resistant Forms of Tuberculosis
May 20, 2019
New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease
Apr 23, 2019
PrimeStore® MTM opens Sputum-free Molecular Screening for M. tuberculosis Infection
Apr 23, 2019
Global BCG Vaccines Sales Market Projected to Garner $65.9 Mn by 2025 at 4.2% CAGR, Says AMR
Apr 18, 2019
TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis (TB)